Status:

COMPLETED

PRebiotic to IMprovE Calcium Absorption

Lead Sponsor:

San Francisco Veterans Affairs Medical Center

Collaborating Sponsors:

University of California, San Francisco

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Obesity

Eligibility:

FEMALE

18-75 years

Phase:

PHASE2

Brief Summary

Gastric bypass surgery is a highly effective treatment for obesity, but it has negative effects on skeletal health, due in part to a dramatic decline in intestinal calcium absorption capacity. Animal ...

Detailed Description

The study is a pilot randomized control trial (RCT) of the effects of the prebiotic SCF vs. placebo in 20 postmenopausal women who underwent Roux-en-Y gastric bypass surgery 2-6 years previously and t...

Eligibility Criteria

Inclusion

  • Postmenopausal women (no menses for ≥4 yrs)
  • ≤ 75 yrs old,
  • Underwent Roux-en-Y gastric bypass surgery for weight loss 2-6 years prior

Exclusion

  • Serum 25(OH)vitamin D level \<30 ng/mL (to remove the effect of vitamin D insufficiency/deficiency)\*
  • History of \>1 bariatric surgical procedure
  • Antibiotic therapy in the last 3 months
  • Regular pre- or probiotic use in the last 3 months
  • Regain of \>50% of weight loss post-bypass
  • Calculated creatinine clearance \<30 mL/min
  • Serum calcium \>10.2 mg/dL
  • Use of hormone therapy, osteoporosis pharmacotherapy, glucocorticoids, or other medications impacting calcium metabolism
  • Thyroid stimulating hormone (TSH) \<0.01 milli-international units per liter (mIU/L)
  • A potential participant may be excluded if she has a condition or abnormality that in the opinion of the Investigator would compromise the safety of the participant or the quality of the data.
  • \*Women excluded due to 25(OH)D level will be offered re-screening after vitamin D supplementation.

Key Trial Info

Start Date :

November 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 31 2020

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03272542

Start Date

November 21 2017

End Date

January 31 2020

Last Update

October 22 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UCSF

San Francisco, California, United States, 94143